Full access
Regular Articles
Published Online: 15 July 2016

Spanish Validation of the Problem Behaviors Assessment–Short (PBA-s) for Huntington’s Disease

Jesús M. Ruiz-Idiago, M.D., Misericordia Floriach, M.D., Cèlia Mareca, Bs.C., Raymond Salvador, Ph.D., José Luis López-Sendón, M.D., Verónica Mañanés, Bs.C., Esther Cubo, M.D., Ph.D., Natividad Mariscal, CNS, Esteban Muñoz, M.D., Pilar Santacruz, Bs.C., María F. Noguera, M.D., Laura Vivancos, Bs.C., Pedro Roy, M.D., Edith Pomarol-Clotet, Ph.D., M.D., and Salvador Sarró, M.D. on behalf of the Spanish Huntington Disease NetworkAuthors Info & Affiliations
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
Volume 29, Number 1
https://doi.org/10.1176/appi.neuropsych.16020025
PDF/EPUBformats

Abstract

A prospective, observational multicenter study was carried out assessing neuropsychiatric symptoms in a sample of 117 subjects in order to validate the Spanish version of the Problem Behaviors Assessment-Short (PBA-s). The psychometric properties of this version were analyzed. Inter- and intra-rater reliability were good: the mean weighted Cohen’s kappa was 0.90 for severity scores and 0.93 for frequency scores. Four factors accounting for 56% of the total variance were identified after an exploratory factor analysis: apathy, irritability, depression, and perseveration. The PBA-s correlates strongly with the Neuropsychiatric Inventory, demonstrating its accuracy for assessing neuropsychiatric symptoms in patients with Huntington’s disease.

Formats available

You can view the full content in the following formats:

View PDF/ePubView Full Text

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Volume 29 • Number 1 • Winter 2017
Pages: 31 - 38
PubMed: 27417071

History

Received: 12 February 2016
Revision received: 22 April 2016
Accepted: 23 April 2016
Published online: 15 July 2016
Published in print: Winter 2017

Authors

Affiliations

Jesús M. Ruiz-Idiago, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Misericordia Floriach, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Cèlia Mareca, Bs.C.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Raymond Salvador, Ph.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
José Luis López-Sendón, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Verónica Mañanés, Bs.C.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Esther Cubo, M.D., Ph.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Natividad Mariscal, CNS
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Esteban Muñoz, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Pilar Santacruz, Bs.C.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
María F. Noguera, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Laura Vivancos, Bs.C.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Pedro Roy, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Edith Pomarol-Clotet, Ph.D., M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
Salvador Sarró, M.D.
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author
on behalf of the Spanish Huntington Disease Network
From the Huntington Disease Programme, Hospital Mare de Déu de la Mercè, Hermanas Hospitalarias, Barcelona, Spain (JR-I, MF, PR); the FIDMAG Hermanas Hospitalarias Research Foundation, Barcelona, Spain (RS, EP-C, SS); the Programa de Doctorat de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain (JR-I); the CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain (RS, EP-C, SS); the Neurology Department, Hospital Ramón y Cajal, Madrid, Spain (JL-S, VM); the Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain (JL-S, VM); the CIBERNED, Instituto de Salud Carlos III, Madrid, Spain (JL-S); the Neurology Department, Complejo Asistencial Universitario Burgos, Burgos (EB), Spain; the Neurology Department, Movement Disorders Unit, Fundació Clinic per la Recerca Biomèdica, Barcelona, Spain (EM, PS, LV); and the Dementia Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain (MN).
View all articles by this author

Notes

Send correspondence to Dr. Ruiz-Idiago; e-mail: [email protected]

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

Agència de Gestió d\'Ajuts Universitaris i de Recerca: 2014SGR1573
Supported by the Catalonian Government (2014SGR1573 to the Research Unit of FIDMAG Hermanas Hospitalarias).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Item saved, go to cart
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share